Particulate and Vesicular Drug Carriers in the Management of Tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|3|1|121-128

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.3, Iss.1, 2006-01, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vesicular Carriers for Skin Drug Delivery: The Pheroid™ Technology

By  

Current Pharmaceutical Design, Vol. 21, Iss. 20, 2015-06 ,pp. : 2758-2770

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Applications of Particulate Carriers in Drug Delivery: Challenges and Future Perspectives

By  

Current Pharmaceutical Design, Vol. 23, Iss. 3, 2017-02 ,pp. : 339-339

Bentham Science Publishers

Access to resources Recommend Favorite

Size Dependent Variations of Phospholipid Based Vesicular Drug Carriers in Systemic Drug Activity

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 4, 2015-04 ,pp. : 380-391

Bentham Science Publishers

Access to resources Recommend Favorite

Iontophoretic Transdermal Delivery of Finasteride in Vesicular Invasomal Carriers

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 2, 2013-04 ,pp. : 136-150

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery

By El-Menshawe Shahira F.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 779-786

Informa Healthcare

Access to resources Recommend Favorite